079f2816_BiblioServet__Guidance
[Reference] TA339 [Programme] Technology appraisal guidance [Topic] Skin conditions: general and other [Guidance] 
Omalizumab for previously treated chronic spontaneous urticaria
BiblioServet
Guidance